CM
UTHR icon

Caption Management’s United Therapeutics UTHR Stock Holding History

Caption Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205M Sell
378,200
-31,800
-8% -$17.9M 0.96% 13
2026
Q1 		$243M Buy
410,000
+250,200
+157% +$125M 1.42% 8
2025
Q4 		$77.9M Sell
159,800
-150,000
-48% -$69.9M 0.53% 34
2025
Q3 		$130M Buy
309,800
+246,600
+390% +$82.9M 1.01% 11
2025
Q2 		$18.2M Buy
63,200
+19,400
+44% +$5.8M 0.2% 99
2025
Q1 		$13.5M Buy
43,800
+23,800
+119% +$8.16M 0.13% 143
2024
Q4 		$7.06M Buy
+20,000
New +$7.35M 0.07% 273
2024
Q3 		– Sell
-20,000
Closed -$6.37M – 1599
2024
Q2 		$6.37M Buy
+20,000
New +$5.29M 0.1% 219
2023
Q4 		– Sell
-15,000
Closed -$3.39M – 1700
2023
Q3 		$3.39M Hold
15,000
– – 0.05% 439
2023
Q2 		$3.31M Buy
+15,000
New +$3.32M 0.06% 381
2022
Q4 		– Sell
-100,000
Closed -$20.9M – 1745
2022
Q3 		$20.9M Buy
100,000
+80,000
+400% +$17.9M 0.29% 63
2022
Q2 		$4.71M Buy
+20,000
New +$4.07M 0.07% 366
2022
Q1 		– Sell
-20,000
Closed -$4.32M – 1974
2021
Q4 		$4.32M Sell
20,000
-34,000
-63% -$6.67M 0.05% 501
2021
Q3 		$9.97M Buy
+54,000
New +$10.6M 0.11% 236
2019
Q4 		– Sell
-25,000
Closed -$1.99M – 1014
2019
Q3 		$1.99M Buy
+25,000
New +$2.01M 0.1% 239

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caption Management's UTHR Position: Q2 2026 in Review

Caption Management reduced its United Therapeutics (UTHR) stake by 87% in Q2 2026, selling an estimated $36.7M and leaving 9,333 shares worth $5.06M. The position accounts for 0.02% of the portfolio, ranked #579.

Caption Management first reported a position in UTHR in Q3 2021 and has held it in 8 quarters since. The position peaked at $44.1M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Caption Management held 9,333 shares of United Therapeutics worth $5.06M as of Q2 2026.
  • Caption Management sold 65,112 United Therapeutics shares in Q2 2026, an estimated $36.7M.
  • United Therapeutics made up 0.02% of Caption Management's portfolio in Q2 2026, its #579 holding.
  • Caption Management first reported a position in United Therapeutics in Q3 2021 and has held it in 8 quarters since.
  • Caption Management's United Therapeutics position peaked at $44.1M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.